We are live on ! Find out more
ASXC

Asensus Surgical, Inc.

Delisted

ASXC was delisted on the 21st of August, 2024.

80 hedge funds and large institutions have $13.5M invested in Asensus Surgical, Inc. in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 22 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

257% more call options, than puts

Call options by funds: $318K | Put options by funds: $89K

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

1% more funds holding

Funds holding: 7980 (+1)

23% less capital invested

Capital invested by funds: $17.5M → $13.5M (-$4M)

59% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 22

Holders
80
Holders Change
+1
Holders Change %
+1.27%
% of All Funds
1.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
9
Reduced
22
Closed
8
Calls
$318K
Puts
$89K
Net Calls
+$229K
Net Calls Change
-$48K

ASXC Hedge Fund Activity: Q2 2023 in Review

80 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q2 2023, worth a combined $13.5M — down 23% from $17.5M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ASXC positions and 8 closed out — a net gain of 1 holder — while 9 added to existing stakes and 22 trimmed.

The largest buyer was Masters Capital Management, adding an estimated $93.8K. The largest seller was Millennium Management, cutting an estimated $121K.

  • 80 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q2 2023, up from 79 in Q1 2023.
  • Funds reported $13.5M of Asensus Surgical, Inc. stock for Q2 2023, down 23% quarter-over-quarter.
  • 9 funds opened new Asensus Surgical, Inc. positions in Q2 2023 and 8 closed out, a net change of +1 holder.
  • The largest Asensus Surgical, Inc. buyer in Q2 2023 was Masters Capital Management, an estimated $93.8K added.
  • The largest Asensus Surgical, Inc. seller in Q2 2023 was Millennium Management, an estimated $121K sold.

Based on aggregated 13F filings for Q2 2023.